WO2005033268A8 - Stem cells for clinical and commercial uses - Google Patents

Stem cells for clinical and commercial uses

Info

Publication number
WO2005033268A8
WO2005033268A8 PCT/US2004/017009 US2004017009W WO2005033268A8 WO 2005033268 A8 WO2005033268 A8 WO 2005033268A8 US 2004017009 W US2004017009 W US 2004017009W WO 2005033268 A8 WO2005033268 A8 WO 2005033268A8
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
present
accordance
body cavity
mammal
Prior art date
Application number
PCT/US2004/017009
Other languages
French (fr)
Other versions
WO2005033268A3 (en
WO2005033268A2 (en
WO2005033268A9 (en
Inventor
Liping Tang
Robert H Hansen
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/857,443 external-priority patent/US20050014255A1/en
Application filed by Univ Texas filed Critical Univ Texas
Priority to EP04809422A priority Critical patent/EP1636341A4/en
Priority to PCT/US2004/017009 priority patent/WO2005033268A2/en
Priority to JP2006515019A priority patent/JP2007525193A/en
Priority to CA002527700A priority patent/CA2527700A1/en
Publication of WO2005033268A2 publication Critical patent/WO2005033268A2/en
Publication of WO2005033268A8 publication Critical patent/WO2005033268A8/en
Publication of WO2005033268A9 publication Critical patent/WO2005033268A9/en
Publication of WO2005033268A3 publication Critical patent/WO2005033268A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/03—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from non-embryonic pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Methods for accumulating, recruiting and retrieving stem cells from a body cavity space of an adult mammal are disclosed, in addition to compositions and cells in accordance with the present invention. In accordance with another aspect of the present invention, a method of obtaining a new source of stem cells is provided by implanting a foreign object in a body cavity space of a mammal and collecting those stem cells resulting from implantation. Further in accordance with the present invention, a method for providing to a subject in need thereof one or more stem cells of the present invention is identified by retrieving stem cells for a body cavity space of a mammal after implanting a foreign object, manipulating the stem cells and introducing the stem cells into the subject in need thereof.
PCT/US2004/017009 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses WO2005033268A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP04809422A EP1636341A4 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses
PCT/US2004/017009 WO2005033268A2 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses
JP2006515019A JP2007525193A (en) 2003-05-29 2004-05-28 Clinical and commercial stem cells
CA002527700A CA2527700A1 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47402003P 2003-05-29 2003-05-29
US60/474,020 2003-05-29
US10/857,443 US20050014255A1 (en) 2003-05-29 2004-05-27 Stem cells for clinical and commercial uses
PCT/US2004/017009 WO2005033268A2 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses

Publications (4)

Publication Number Publication Date
WO2005033268A2 WO2005033268A2 (en) 2005-04-14
WO2005033268A8 true WO2005033268A8 (en) 2005-06-02
WO2005033268A9 WO2005033268A9 (en) 2005-09-15
WO2005033268A3 WO2005033268A3 (en) 2006-03-23

Family

ID=46123777

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017009 WO2005033268A2 (en) 2003-05-29 2004-05-28 Stem cells for clinical and commercial uses

Country Status (4)

Country Link
EP (1) EP1636341A4 (en)
JP (1) JP2007525193A (en)
CA (1) CA2527700A1 (en)
WO (1) WO2005033268A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008100936A2 (en) 2007-02-12 2008-08-21 Cedars-Sinai Medical Center Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavity
EP2146728A4 (en) 2007-05-21 2010-12-29 Univ Wake Forest Health Sciences Progenitor cells from urine and methods for using the same
WO2010065239A1 (en) 2008-12-05 2010-06-10 Wake Forest University Health Sciences Stem cells from urine and methods for using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
AU4221399A (en) * 1998-05-29 1999-12-13 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
EP2322601A1 (en) * 2000-12-06 2011-05-18 Anthrogenesis Corporation Method of collecting placental stem cells
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis

Also Published As

Publication number Publication date
CA2527700A1 (en) 2005-04-14
JP2007525193A (en) 2007-09-06
EP1636341A2 (en) 2006-03-22
WO2005033268A3 (en) 2006-03-23
WO2005033268A2 (en) 2005-04-14
EP1636341A4 (en) 2007-08-01
WO2005033268A9 (en) 2005-09-15

Similar Documents

Publication Publication Date Title
HK1252977A1 (en) Method of collecting placental stem cells
WO2004007697A3 (en) Methods of implanting mesenchymal stem cells for tissue repair and formation
EP1537883A3 (en) Implants comprising viable tissue for repairing a tissue injury or defect
WO2006004910A3 (en) Improved bispecific antibodies
WO2002083864A3 (en) Methods and reagents for cell transplantation
WO2006050330A3 (en) Platelets from stem cells
WO2006001938A3 (en) Methods and compositions for producing germ cells from bone marrow derived germline stem cells
EP1491093A3 (en) Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
WO2006017134A3 (en) Preprimitive streak and mesendoderm cells
EP1627047A4 (en) Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
EP2471904A3 (en) Placental stem cell populations
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
WO2005018468A3 (en) Surgical implant
DK2105497T3 (en) Progenitor cell populations, their expansion, and growth of non-hematopoietic cell types and tissues therefrom
WO2004034890A3 (en) Biological scaffolding material
WO2006033103A3 (en) Compositions and methods for stem cell expansion and differentiation
EA200900806A1 (en) METHODS OF INCREASING THE NUMBER AND MOBILIZATION OF HEMOPOETIC STEM CELLS
ES2530872T3 (en) Organs and cells modified for xenotransplantation
WO2006093860A3 (en) Method and composition for repairing heart tissue
WO2003046161A3 (en) Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells
WO2007063545A3 (en) Methods of improving stem cell homing and engraftment
PL1733024T3 (en) Method for the production of a cell composition containing epithelial cells
WO2005033268A8 (en) Stem cells for clinical and commercial uses

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480019015.7

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 15/2005 UNDER (30) ADD "US"

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
COP Corrected version of pamphlet

Free format text: PAGES 1/14-14/14, DRAWINGS, REPLACED BY NEW PAGES 1/14-14/14; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWE Wipo information: entry into national phase

Ref document number: 2527700

Country of ref document: CA

Ref document number: 2006515019

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2004809422

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2004809422

Country of ref document: EP